This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Systemic Mastocytosis Treatment Market

Systemic Mastocytosis Treatment Market By Drug Class (Antihistamines, Tyrosine Kinase Inhibitors, Steroids, Mast-cell stabilizers), Indication (Aggressive Systemic Mastocytosis (ASM), Mast Cell Leukemia (MCL)), Route of Administration (Oral, Injectables, Topical) & Region - Forecast 2022-2032

Market Insights on Systemic Mastocytosis Treatment covering sales outlook, demand forecast & up-to-date key trends

Systemic Mastocytosis Treatment Market Overview

The global demand for systemic mastocytosis treatment is slated to grow at a moderate CAGR of around 5% to 5.6% CAGR during the forecast period from 2022 to 2032. Growth in the market is driven by rising prevalence of systemic mastocytosis across the globe and development of new treatment drugs.

Report Attribute

Details

Systemic Mastocytosis Treatment Market Projected Growth Rate (2022-2032)

5% - 5.6% CAGR

Systemic mastocytosis is a rare disease or blood disorder generally caused by KIT gene mutation that results in too many mast cells building up in a patient's body. The condition often leads to excessive accumulation of mast cells in skin, bone marrow, liver, digestive tract and several other body organs. This in turn causes several mild to severe symptoms.

There are various subtypes of systemic mastocytosis including indolent systemic mastocytosis, aggressive systemic mastocytosis, systemic mastocytosis associated with hematologic non-mast cell lineage disorder, and mast cell leukemia, depending on the indication. Among these indolent systemic mastocytosis is the mildest form of systemic mastocytosis while mast cell leukemia, aggressive systemic mastocytosis, and systemic mastocytosis associated with hematologic non-mast cell lineage disorder are severe ones. The severe forms of systemic mastocytosis can significantly reduce the life span of patients.

Although there is no permanent treatment currently available for this condition, various drugs such as antihistamines, proton pump inhibitors, steroids, tyrosine kinase inhibitors, epinephrine, and mast-cell stabilizers are being used for relieving the symptoms. Rising consumption of these drug classes for treating and minimizing the symptoms as well as improving the quality of life is a major force behind the expansion of systemic mastocytosis treatment market.

Leading market players are increasingly investing in research and development activities to develop and evaluate possible treatment options that can effectively eliminate the symptoms of systemic mastocytosis.

Which are Some Prominent Drivers Spearheading Systemic Mastocytosis Treatment Market Growth?

The swift expansion of systemic mastocytosis treatment market is attributed to the rising prevalence of systemic mastocytosis worldwide, growing awareness among people about systemic mastocytosis, its diagnosis and treatment, advancements in treatments options, and increasing government support.

Systemic mastocytosis treatments such as antihistamines, tyrosine kinase inhibitors, proton pump inhibitors, Epinephrine, and Steroids have become ideal options for treating and relieving multiple symptoms of systemic mastocytosis. They are being increasingly consumed by patients suffering from systemic mastocytosis to improve their quality of life. This factor is likely to provide a strong push to the growth of systemic mastocytosis treatment market during the forecast period.

Similarly, various government and non-government organizations are putting various efforts to reduce the global burden of systemic mastocytosis. They are launching various awareness programs to educate people about this condition, its diagnosis and treatment. This will continue to boost market growth in the forthcoming years.

Additionally, rising investments in research and development by key market players coupled with increasing novel drug launches and approvals is expected to further expand the systemic mastocytosis treatment market size during the assessment period.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Systemic Mastocytosis Treatment Industry?

Despite a positive growth trajectory, the global mastocytosis treatment market is facing various challenges that are slowing down its growth. Some of these factors are the low diagnostic rates, lack of awareness about the condition and availability of its treatment, rising costs of treatment, and side effects associated with various treatment drugs.

What is the Demand Outlook for the North America Market?

With rising prevalence of systemic mastocytosis, presence of leading market players, and availability of several treatment drugs, North America spearheaded by the U.S., is expected to continue its dominance in the global systemic mastocytosis treatment market during the assessment period.

The U.S. is home to some of the major pharmaceutical and biotechnological companies of the world. These companies are continuously striving to launch innovative treatment solutions for rare diseases like systemic mastocytosis. This is emerging as a key factor in boosting the growth of systemic mastocytosis market across the region.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to Growth of the Systemic Mastocytosis Treatment Market?

According to Future Market Insights, Europe will continue to remain the second most lucrative market on account of higher patient pool, growing healthcare awareness among people, and rising adoption of systemic mastocytosis treatment for minimizing and eradicating various symptoms.

Moreover, rapid expansion of healthcare industry coupled with increase in drug research and development activities across countries like the United Kingdom and France is positively impacting the market growth.

Market Competition

Some of the key participants present in the global systemic mastocytosis treatment market include Merck & Co. Inc., Bausch Health Companies Inc., Sanofi S.A., Pfizer Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., Novartis AG, Johnson & Johnson, Bayer AG, Mallinckrodt Pharmaceuticals, EPI Health, LLC, and Kaleo Inc.

These market players are vigorously investing in research and development for introducing novel treatments for systemic mastocytosis. Besides this, they have adopted various growth strategies such as acquisitions, partnerships, price reduction, new product launches and approvals, strengthening of distribution channels, and launch of awareness campaigns to gain a competitive edge in the market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5% - 5.6% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Drug Class
  • Indication
  • Route of Administration
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Merck & Co. Inc.
  • Bausch Health Companies Inc.
  • Sanofi S.A.
  • Pfizer Inc.
  • Mylan NV
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Johnson & Johnson
  • Bayer AG
  • Mallinckrodt Pharmaceuticals
  • EPI Health, LLC
  • Kaleo Inc.

Customization

Available Upon Request

Key Segments Profiled in the Systemic Mastocytosis Treatment Industry Survey

By Drug Class:

  • Antihistamines
  • Tyrosine Kinase Inhibitors
  • Proton pump inhibitors
  • Epinephrine
  • Steroids
  • Mast-cell stabilizers

By Indication:

  • Indolent systemic mastocytosis (ISM)
  • Systemic Mastocytosis associated with Hematologic Non-mast Cell Lineage Disorder (SM-AHNMD)
  • Aggressive systemic mastocytosis (ASM)
  • Mast cell leukemia (MCL)

By Route of Administration:

  • Oral
  • Injectables
  • Topical

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa

Frequently Asked Questions

FMI projects the global systemic mastocytosis treatment market to expand at around 5% to 5.6% CAGR over the assessment period from 2022 to 2032.

North America is expected to remain the most lucrative market for systemic mastocytosis treatment during the forecast period.

Merck & Co. Inc., Bausch Health Companies Inc., Sanofi S.A., Pfizer Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., and Novartis AG are some prominent players operating in the systemic mastocytosis treatment market.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Systemic Mastocytosis Treatment Market